LabCorp Is Scheduled to Present at the Bear Stearns 2007 Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--Sept. 7, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T.

Conversion Right Triggered for Labcorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Jul 24, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be

Laboratory Corporation of America(R) Holdings Announces 2007 Second Quarter Results

Second Quarter Net Sales Growth of 15.4% Drives EPS Increase of 20.7% BURLINGTON, N.C., July 24 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the quarter and six months ended June 30, 2007.

LabCorp is Scheduled to Present at the Jefferies 2007 Healthcare Conference

BURLINGTON, N.C.--(BUSINESS WIRE)--June 25, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T. Smith, Executive Vice President, Corporate Affairs, are

Laboratory Corporation of America(R) Holdings Agrees to Acquire DSI Laboratories from NCH Healthcare System

NAPLES, Fla.--(BUSINESS WIRE)--June 18, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE-LH), an S&P 500 company and one of the world's premier clinical laboratories, has agreed to acquire DSI Laboratories, Inc., a full-service medical reference and toxicology laboratory

LabCorp Announces Contract Extension with CIGNA HealthCare

BURLINGTON, N.C., Jun 06, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that it has executed a multi-year clinical laboratory services contract renewal with CIGNA HealthCare. LabCorp will continue to be a contracted laboratory provider

LabCorp Is Scheduled to Present at the Bank of America 2007 Health Care Conference

BURLINGTON, N.C., May 30, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that David P. King, Chief Executive Officer, William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, and Bradford T.

LabCorp to Be First Commercial Laboratory to Offer FDA Approved, Fully Automated Real-Time HIV Test from Roche Diagnostics

New Test Format Will Help Doctors Tailor Patient Treatment, Enhance Total Quality Process and Simplify Testing BURLINGTON, N.C., May 21, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE:LH), one of the world's leading clinical laboratories, today announced an

LabCorp(R) Licenses Integrated and Sequential Prenatal Screening Technology for Down Syndrome from Intema

More Sensitive Technology Improves Assessment of Down Syndrome Risk BURLINGTON, N.C., May 16, 2007 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH), an industry leader in prenatal clinical laboratory testing, announced today that it has entered into an

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C.--(BUSINESS WIRE)--May 15, 2007--Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 16, 2007 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com.